Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Tazarotene gel may be more effective for acne than adapalene gel.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Baricitinib may effectively treat oral lichen planus.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Biosimilars lower costs but don't significantly improve access.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Intralesional vitamin D3 is an effective and safe treatment for patchy alopecia areata with fewer side effects.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.